Literature DB >> 22214336

Regulation of leptin receptor expression in human polarized Caco-2/15 cells.

Philippe G Cammisotto1, Moise Bendayan, Emile Levy.   

Abstract

BACKGROUND: Leptin receptors (LEPR) are expressed in intestinal epithelial cells from the duodenum to the colon. Since their role is fundamental for the proper control of nutrient absorption, mucus secretion and mucosa renewal, the regulation of LEPR expression is for the first time investigated as a function of various potential effectors. METHODOLOGY/PRINCIPAL
FINDINGS: Fully differentiated Caco-2/15 cells were incubated for 24 hours with nutrients [carbohydrates, fatty acids (FA), amino acids and sterols], hormones (leptin, insulin, hydrocortisone and epithelial growth factor), inflammatory agents (Interferon-γ, LPS, TNF-α), and PPAR agonists (rosiglitazone and WY14643). Levels of LEPR mRNA and protein expressions were measured by RT-PCR and Western blots, respectively.
RESULTS: Long (219.1) and short (219.3) isoforms of the LEPR were detected in Caco-2/15 cells, while absence of the isoform 219.2 was noted. Their gene expression was modulated by carbohydrates, FA, PPAR agonists, biliary salts, insulin and leptin itself. On the other hand, LEPR protein expression was modulated by FA, cholesterol, biliary salts, PPAR agonists and insulin. Interestingly, the same effectors may have opposite effects on the short and the long LEPR isoforms, as well as on mRNA and protein levels. Finally, Caco-2/15 cells were found to be sensitive to the effector location, i.e. apical or basolateral compartment.
CONCLUSIONS/SIGNIFICANCE: Our results suggest that (i) the expression of LEPR in Caco-2/15 cell line is not constitutive; (ii) the agents present in the apical or basolateral medium have different effects on LEPR mRNA and/or protein levels; and (iii) short and long isoforms of LEPR follow different patterns of regulation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22214336     DOI: 10.2174/187153012799279027

Source DB:  PubMed          Journal:  Endocr Metab Immune Disord Drug Targets        ISSN: 1871-5303            Impact factor:   2.895


  7 in total

1.  Overexpression of gastric leptin precedes adipocyte leptin during high-fat diet and is linked to 5HT-containing enterochromaffin cells.

Authors:  J Le Beyec; A-L Pelletier; K Arapis; M Hourseau; F Cluzeaud; V Descatoire; R Ducroc; T Aparicio; F Joly; A Couvelard; J-P Marmuse; M Le Gall; A Bado
Journal:  Int J Obes (Lond)       Date:  2014-01-28       Impact factor: 5.095

2.  Altered gastric vagal mechanosensitivity in diet-induced obesity persists on return to normal chow and is accompanied by increased food intake.

Authors:  S J Kentish; T A O'Donnell; C L Frisby; H Li; G A Wittert; A J Page
Journal:  Int J Obes (Lond)       Date:  2013-07-30       Impact factor: 5.095

3.  Basal leptin regulates amino acid uptake in polarized Caco-2 cells.

Authors:  Carmen Fanjul; Jaione Barrenetxe; María Pilar Lostao
Journal:  J Physiol Biochem       Date:  2013-01-30       Impact factor: 4.158

4.  SAR1B GTPase is necessary to protect intestinal cells from disorders of lipid homeostasis, oxidative stress, and inflammation.

Authors:  Alain Sané; Lena Ahmarani; Edgard Delvin; Nikolas Auclair; Schohraya Spahis; Emile Levy
Journal:  J Lipid Res       Date:  2019-08-13       Impact factor: 5.922

5.  Maternal obesity influences expression and DNA methylation of the adiponectin and leptin systems in human third-trimester placenta.

Authors:  Perrine Nogues; Esther Dos Santos; Hélène Jammes; Paul Berveiller; Lucie Arnould; François Vialard; Marie-Noëlle Dieudonné
Journal:  Clin Epigenetics       Date:  2019-02-07       Impact factor: 6.551

6.  Leptin-mediated differential regulation of microsomal triglyceride transfer protein in the intestine and liver affects plasma lipids.

Authors:  Jahangir Iqbal; Eduardo Mascareno; Streamson Chua; M Mahmood Hussain
Journal:  J Biol Chem       Date:  2020-02-11       Impact factor: 5.157

7.  Immunolocalization of leptin and leptin receptor in colorectal mucosa of ulcerative colitis, Crohn's disease and control subjects with no inflammatory bowel disease.

Authors:  Flavia Merigo; Alessandro Brandolese; Sonia Facchin; Federico Boschi; Marzia Di Chio; Edoardo Savarino; Renata D'Incà; Giacomo Carlo Sturniolo; Andrea Sbarbati
Journal:  Cell Tissue Res       Date:  2020-11-07       Impact factor: 5.249

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.